Feedback / Questions
ondansetron ultra-low dose (AD04) - ADial
https://www.globenewswire.com/news-release/2021/07/06/2258338/26135/en/The-Phase-3-ONWARD-Trial-Meets-its-Screening-Target-and-Nears-Enrollment-Completion.html
Jul 6, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next